We strive to provide a full range of educational opportunities for physicians, nurses and patients in the treatment of disease and are active in the recruitment of patients for up-to-date clinical protocol for evaluation of therapeutic diagnostic modalities throughout Surgical Oncology.
The Endocrine Surgery program specializes in surgical treatment of endocrine diseases. This is primarily dedicated to the evaluation and surgical management of benign and malignant diseases of the thyroid, parathyroid, and adrenal glands. For all of these procedures, there is good evidence that patient outcomes are significantly improved by having these operations performed by a “high-volume” surgeon. Endocrine Surgeons at UVA are high volume in all of these areas.
Endocrine Surgeons have received specialty training regarding the medical aspects of these glands, the lab work and imaging studies particular to these glands, and the latest in surgical techniques to manage diseases of these glands. Endocrine Surgeons work closely with physicians from Medical Endocrinology, Primary Care, Pathology, Radiology, Nuclear Medicine, Anesthesiology and others to provide true integrated and multidisciplinary care. Endocrine Surgeons at UVA offer a broad spectrum of surgical approaches including minimally invasive techniques as well as open procedures when appropriate.
The HPB (Hepato-pancreato-biliary) team (comprised of Dr. Adams, Bauer and Zaydfudim) within the Department of Surgery has a long history of excellence and national leadership in providing comprehensive care for patients with malignant and benign conditions of the pancreas, liver and biliary system, as well as the stomach, duodenum, and small intestine. This group works in close cooperation with members of the Cancer Center, the Digestive Health Center, and many other specialists at UVA. Specifically, patients are seen and evaluated in clinic, receive either surgical or non-surgical evaluation and are evaluated on an acute or chronic basis. When appropriate patients are reviewed at the UVA Multidisciplinary Gastrointestinal Conference (Tumor Board) for input regarding optimal management.
Patients at risk for pancreatic cancer who require continued surveillance are then seen in the UVA High Risk Pancreatic Cancer Clinic, which is led by Dr. Bauer.
High Risk Pancreatic Cancer Clinic
About the Whipple Procedure
Pancreatic Cancer Research
Dr. Bauer is a leading expert in the management of patients with sarcoma and other soft tissue tumors. These rare tumors may arise in the abdominal cavity or pelvis, arms, legs, or trunk and may be malignant or benign. Optimal outcome for patients requires a thoughtful work-up by a clinician with specific expertise in these rare tumors. Radiographic imaging (ultrasound, CT, or MRI) will be performed when appropriate and biopsy will be performed when appropriate. Many tumors are best treated with surgical excision, whereas some tumors may be left alone. For malignant tumors, additional therapy is recommended for some patients and may consist of radiation and/or chemotherapy. The decision for radiation and chemotherapy and the timing of these (before versus after surgery) is tailored to each patient. Dr. Bauer works closely with other Cancer Center members in Medical Oncology and Radiation Oncology to provide optimal, team-based care for patients with sarcoma and other soft tissue tumors.